These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8546603)

  • 1. [Substitutive treatment of renal function].
    Abensur H
    Arq Bras Cardiol; 1995 Jul; 65(1):81-3. PubMed ID: 8546603
    [No Abstract]   [Full Text] [Related]  

  • 2. Early dialysis initiation and renal function trajectory.
    Rosansky S
    J Intern Med; 2011 Mar; 269(3):275-7. PubMed ID: 21083856
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it time to revisit residual renal function in haemodialysis?
    Ng TG; Johnson DW; Hawley CM
    Nephrology (Carlton); 2007 Jun; 12(3):209-17. PubMed ID: 17498114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis: Advances in Chronic Kidney Disease. Preface.
    Ronco C; Levin NW
    Blood Purif; 2008; 26(1):5. PubMed ID: 18182787
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sustained low-efficiency dialysis (SLED) in patients with prevalent systolic heart failure refractory to medical treatment and with chronic renal failure].
    Iorio L; Violi F; Simonelli R; Nacca RG; Rossi G; Caliendo A; Lamberti F; Mantella D
    G Ital Nefrol; 2006; 23 Suppl 34():S71-3. PubMed ID: 16634000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodialysis in infants.
    Vaartjes H; Frankhuisen J; Veuger A
    EDTNA ERCA J; 1996; 22(4):24-5, 28. PubMed ID: 10723344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual renal function: the delicate balance between benefits and risks.
    Canaud B
    Nephrol Dial Transplant; 2008 Jun; 23(6):1801-5. PubMed ID: 18344238
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic overdrive: a 'not-so-sympathetic' risk factor in renal failure patients.
    Jordan J; Grassi G
    J Hypertens; 2007 Jun; 25(6):1197-9. PubMed ID: 17563531
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodialysis for end-stage renal disease: options and strategies.
    Adams MB
    Semin Vasc Surg; 1997 Sep; 10(3):151-6. PubMed ID: 9304731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suddenly speechless florist on chronic dialysis: the unexpected threats of a flower shop? Diagnosis: dialysis related Wernicke encephalopathy.
    Barbara PG; Manuel B; Elisabetta M; Giorgio S; Fabio T; Valentina C; Emanuela M; Massimo B; Giuseppe S; Paolo SG
    Nephrol Dial Transplant; 2006 Jan; 21(1):223-5. PubMed ID: 16280376
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter?
    Grooteman MP; Nubé MJ
    Nephrol Dial Transplant; 2004 Dec; 19(12):2965-70. PubMed ID: 15507481
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [By how much can the duration of dialysis sessions be shortened? To shorten can be harmful].
    Petitclerc T; Jacobs C
    Rev Prat; 1991 Sep; 41(20):1930-4. PubMed ID: 1925378
    [No Abstract]   [Full Text] [Related]  

  • 14. What about daily dialysis, doc?
    Snyder D
    ASAIO J; 2003; 49(4):349. PubMed ID: 12918572
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral health in patients with chronic renal failure].
    Bots CP; Brand HS; Franse RL; van Nieuw AA
    Ned Tijdschr Tandheelkd; 2006 May; 113(5):182-5. PubMed ID: 16729562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dialysis treatment of infants with end stage failure].
    Sandvig HV; Gustavsen A; Solberg R; Simonsen S; Bjerre A; Kyte A; Rootwelt T
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3069-72. PubMed ID: 18049497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in managing anemia in patients returning to dialysis after transplant failure.
    Wilson S
    Nephrol Nurs J; 2008; 35(4):383-6. PubMed ID: 18783000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
    Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
    Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to preserve residual renal function in patients with chronic kidney disease and on dialysis?
    Krediet RT
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii42-6. PubMed ID: 16825260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.